Tirzepatide represents a groundbreaking treatment agent for individuals facing type 2 diabetes. As a dual receptor activator, it targets both the glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic https://aisharkln906001.blog-eye.com/40904027/tirzepatide-a-game-changer-for-type-2-diabetes